Atara Biotherapeutics
ATRA
ATRA
145 hedge funds and large institutions have $1.34B invested in Atara Biotherapeutics in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 48 increasing their positions, 53 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
-6
Holders Change %
-3.97%
% of All Funds
2.53%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
18
Increased
48
Reduced
53
Closed
24
Calls
$426K
Puts
$436K
Net Calls
-$10K
Net Calls Change
-$711K
Top Buyers
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$23.3M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
$120M |
| 3 |
JPMorgan Chase & Co
New York
|
$117M |
| 4 |
BlackRock
New York
|
$120M |
| 5 |
Goldman Sachs
New York
|
$40.4M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
$0 |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$4.29M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
$19.1M |
| 4 |
AG
Artal Group
Luxembourg
|
$23.3M |
| 5 |
Two Sigma Investments
New York
|
$7.52M |
